In 2008, dengue virus serotype 4 (DENV-4) emerged in northeastern Peru, causing a large outbreak and displacing DENV-3, which had predominated for the previous 6 years. Phylogenetic analysis of 2008 and 2009 isolates support their inclusion into DENV-4 genotype II, forming a lineage distinct from strains that had previously circulated in the region.
In 2008, dengue virus serotype 4 (DENV-4) emerged in northeastern Peru, causing a large outbreak and displacing DENV-3, which had predominated for the previous 6 years. Phylogenetic analysis of 2008 and 2009 isolates support their inclusion into DENV-4 genotype II, forming a lineage distinct from strains that had previously circulated in the region.
I
nfection by any 1 of 4 distinct dengue virus serotypes (DENV-1 through DENV-4) can result in disease manifestations ranging from asymptomatic or mild to severe outcomes, including dengue hemorrhagic fever (DHF) and dengue shock syndrome. Several lines of evidence point toward secondary infection by a heterologous serotype as one of the critical risk factors for DHF (1) , underscoring the need to monitor circulating DENV serotypes and genotypes.
In Latin America, >30 countries and regions have reported DENV circulation, totaling >900,000 dengue fever cases, 26,000 DHF cases, and 300 deaths in 2007 (2) . Following the breakdown of a hemisphere-wide Aedes aegypti mosquito eradication campaign conducted in the mid-20th century, vector populations expanded and all 4 DENV serotypes reemerged or were reintroduced into the Western Hemisphere. Outbreaks of DENV-2 and DENV-3 were fi rst detected in the 1960s, followed by the introduction of DENV-1 in 1977 and DENV-4 in 1981 (3, 4) .
Since its introduction into the Americas in 1981, DENV-4 has circulated continuously in the Caribbean basin (5) and northern South America with little evidence of widespread transmission further south into the continent during the past 25 years (4, 6, 7) . We report the emergence of DENV-4 strains belonging to genotype II in the tropical rainforest and coastal regions of northern Peru, replacing DENV-3 subtype III (8) as the predominant strain in the region.
The Study
Patients with acute, undifferentiated, febrile illness were recruited into a clinic-based surveillance study conducted jointly by the US Naval Medical Research Center Detachment (NMRCD) and the Peruvian and Ecuadorian Institutes of Health (Figure 1 To characterize the DENV-4 isolates, a 1,485-bp sequence covering the entire mature envelope (E) gene was amplifi ed and sequenced from a representative set of viruses from Guayaquil (n = 6), Tumbes (n = 6), Piura (n = 2), Trujillo (n = 1), Iquitos (n = 9), Yurimaguas (n = 7), and Lima Figure 2 . Phylogenetic analysis of the envelope gene of dengue virus serotype 4 (DENV-4) strains from Ecuador, Peru, and Venezuela. Similar topologies were observed from neighbor-joining (depicted), maximum likelihood, and maximum parsimony analyses, implemented in PAUP* v.4.0b10 (12) . The general time reversible model of evolution was used for neighbor-joining and maximumlikelihood analyses. DENV-4 genotype I strains (not shown) were included as an outgroup. Bootstrap values (based on 1,000 replicates) >65 are shown at major nodes. Isolates fi rst reported in this study are shown in boldface and with sample identifi cation code. Some sequenced isolates from Peru and Venezuela that share high nucleotide identity (>99.7%) with depicted strains were omitted to reduce redundancy and improve clarity of the fi gure. Sequences were deposited in the GenBank database under the accession nos. GQ139572-GQ139577 (Ecuador), GQ139547-GQ139571 (Peru), and GQ139578-GQ139591 (Venezuela). Scale bar indicates number of nucleotide substitutions per site.
distinct from previously published DENV-4 Caribbean basin strains (9, 10) , with strong bootstrap support ( Figure  2 ). This lineage is distinguished from previously reported DENV-4 genotype II strains by 3 conserved amino acid variations in the E protein: S64L, A235T, and S403A.
Conclusions
We report DENV-4 expanding rapidly through northern Peru, particularly in the Loreto Department in the tropical rainforest region, spreading through a population immunologically naïve to this serotype. In the past 2 decades, populations in northern Peru have been exposed to the other 3 DENV serotypes, thus increasing the possibility for severe disease, including DHF. In Iquitos, DHF was fi rst reported during a DENV-3 epidemic in 2004 (M. Sihuincha and C. Rocha, pers. comm.). DHF had not been observed after the introduction of DENV-2 despite large numbers of infected residents (13) , presumably due to cross-protection afforded by prior infection with DENV-1 (14) . For the currently circulating lineage of DENV-4, the levels of either cross-protection or antibody-dependent enhancement of infection resulting from prior heterologous infection remain to be determined.
The mechanisms responsible for DENV-3 displacement in Loreto are unclear. Following several years of DENV-3 circulation in the region, serotype-specifi c antibody prevalence is high (≈45% of the population, based on virus neutralization assays [T.J. Kochel, unpub . data]). However, it is unlikely that herd immunity is suffi cient to explain the dramatic decrease in DENV-3 transmission. The presence of broadly cross-protective antibodies during the acute and early convalescent phases following DENV-4 infection, when combined with the large number of DENV-3 immune persons, could suppress transmission of DENV-3 strains (15) . Another possibility is serotype competition within the vector species. Analysis of virus strains from Ae. aegypti mosquitoes collected during the transitional period could help elucidate whether such intertypic competition is occurring.
Genetically, the 2006-2009 isolates analyzed in this study do not appear to be related to viruses collected from Ecuador and northern Peru during 2000, which were similar to the initial Latin American introduction strains (Figure 2) . Instead the 2006-2009 isolates were most closely related to viruses from Venezuela collected during 2000 through 2007, forming a lineage distinct from the DENV-4 genotype II B4 lineage (10) . Genetic conservation among isolates from Peru and similarity with isolates from Venezuela support an introduction event into northern Peru and Ecuador from the northern region of South America before 2006, and a subsequent introduction from coastal Peru into Loreto, although more data from other regions of South America and the Caribbean basin would be necessary to more clearly delineate the geographic spread of this virus strain.
